作者：
Clément,Veys [1]
;
Flavie,Boulouard [1]
;
Abderrahim,Benmoussa [2]
;
Manon,Jammes [1]
;
Emilie,Brotin [3]
;
Françoise,Rédini [1]
;
Laurent,Poulain [4]
;
Nicolas,Gruchy [5]
;
Christophe,Denoyelle [6]
;
Florence,Legendre [7]
;
Philippe,Galera [5]
作者单位：
Normandie Univ., UNICAEN, BIOTARGEN, Caen, France.
[1]
Department of Genetics, Normandy Center for Genomic and Personalized Medicine, Caen University Hospital, Caen, France.
[2]
Research Center of the UHC Sainte-Justine and Department of Nutrition, Université de Montréal, Montréal, QC, Canada.
[3]
Normandie Univ., UNICAEN, Federative Structure Normandie Oncology, US Platon, ImpedanCELL Platform, Caen, France.
[4]
Normandie Univ., UNICAEN, INSERM U1086 ANTICIPE, Biology and Innovative Therapeutics for Ovarian Cancer (BioTICLA), Caen, France.
[5]
UNICANCER, Comprehensive Cancer Center F. Baclesse, Caen, France.
[6]
UMR 1238 Phy-Os "Bone Sarcomas and Remodeling of Calcified Tissues", INSERM, Nantes University, Nantes, France.
[7]
DOI
10.3389/fonc.2023.1220459
PMID
37719019
发布时间
2023-09-19
换一批
换一批
